ACURA PHARMACEUTICALS, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • April 18th, 2013 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 18th, 2013 Company Industry JurisdictionAcura Pharmaceuticals, Inc., a New York corporation (the “Company”), confirms its agreement (this “Agreement”), with MLV & Co. LLC (“MLV”), as follows: